Skip to main content

Stephen Bloch

Stephen Bloch

General Partner / East Coast, Caanan Partners
Image
Steve Bloch.jpg

A former entrepreneur and practicing physician, Steve knows firsthand the challenges of building successful healthcare companies. Unfazed by the complexity in healthcare, whether regulatory, technical or market driven, Steve's mission at Canaan Partners has been to invest in companies that make healthcare delivery more effective. Steve currently serves on the boards of companies in biopharma (Liquidia (LQDA - NASDAQ, board chairman, audit and compensation committees), digital health (Truveris, Ambra Health, Corvium and Genome Medical), and medical devices (Onkos Surgical). Past public company board roles include Marinus Pharmaceuticals (MRNS-NASDAQ) and Amicus Therapeutics (FOLD-NASDAQ). Steve is also a member of Dartmouth Medical School's Board of Advisors. Before joining Canaan in 2002, Steve helped found and manage multiple start-ups, including Radiology Management Sciences (RMS) where he was CEO for 6 years, OmniSonics Medical Technologies and TeleRad. Previously, Steve was a strategic pharmaceutical consultant for Arthur D. Little.

Functional Expertise: Research and development, Business Development, Operations